Company Overview

Development Stage

About the Company

恒赛生物成立于2018年,在上海设有研发中心,是一家专注于肿瘤免疫疗法领域的高新技术企业,主要从事新一代个体化树突细胞肿瘤治疗疫苗(DC疫苗)的研发与产业化,旨在开发具有自主知识产权的*、国内首创、普惠性强、安全方便的DC疫苗产品。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

恒赛生物 Financing History (4 rounds)

Manage
战略投资
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 融资金额未公开
  • Investor: 天士力创投

恒赛生物 honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

恒赛生物 Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 837.4423万(元)
Legal Representative: 刘慧宁
Date Established:
Credit Code: 91442000MA7GY5NF2E
Registered Address: 中山市翠亨新区香山大道34号创新中心厂房C栋4楼409室-40卡

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates